Trump struck deals with 16 drug companies. But they're still raising prices this year

Pfizer CEO Albert Bourla joined President Donald Trump at the podium in the White House on Sept. 30, to announce a voluntary effort to reduce some drug prices. Pfizer was the first of 16 companies to announce a deal with the Trump administration, but the details remain under wraps.

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.

(Image credit: Win McNamee)